Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2004 Apr 27;170(9):1371-2; author reply 1372-4.
doi: 10.1503/cmaj.1031912.

Drug therapy for Alzheimer's disease

Shane Kavanagh, Patricia Kabathova
Comment

Drug therapy for Alzheimer's disease

Shane Kavanagh et al. CMAJ. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Lanctôt KL, Herrmann N, Yau KK, Khan LR, Liu BA, LouLou MM, et al. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. CMAJ 2003;169(6):557-64. - PMC - PubMed
    1. Schneider L. CIBIC+: What, why and how? Alzheimer Insights 1997;Jun:2-8.
    1. Raskind MA, Peskind PR, Wessel T, Yuan W. Galantamine in AD: a 6-month randomised, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology 2000;54:2261-8. - PubMed
    1. Wilcock G, Lilienfeld S, Gaens E. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: a multi-centre randomised controlled trial. Galantamine International-1 Study Group. BMJ 2000;321:1445-9. - PMC - PubMed
    1. Tariot PN, Solomon PR, Morris JC, Kershaw P. A 5-month, randomised, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. Neurology 2000;54:2269-76. - PubMed

MeSH terms